Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 20 studies with search of: | "Palonosetron" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients
|
||||
2 | Recruiting |
Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)
|
||||
3 | Recruiting |
Aloxi for Prevention of Acute and Delayed Chemotherapy Induced Nausea and Vomiting (CINV) in Malignant Glioma (MG) Patients Receiving Irinotecan With Bevacizumab
|
||||
4 | Active, not recruiting |
Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting
|
||||
5 | Completed |
Safety and Efficacy of Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting
|
||||
6 | Completed |
Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy
|
||||
7 | Recruiting |
Palonosetron, Aprepitant, and Low-Dose Dexamethasone in Preventing Nausea and Vomiting in Patients Undergoing High-Dose Chemotherapy and Stem Cell Transplant for Multiple Myeloma or Lymphoma
|
||||
8 | Recruiting |
Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors
|
||||
9 | Completed |
An Efficacy and Safety Study of Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in the Chinese Cancer Patients
|
||||
10 | Recruiting |
POWS: Palonosetron/Ondansetron Opioid Withdrawal Study
|
||||
11 | Completed |
Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)
|
||||
12 | Recruiting |
Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
|
||||
13 | Completed |
Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)(COMPLETED)
|
||||
14 | Recruiting |
Dexamethasone and Ondansetron or Palonosetron in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy for Early-Stage Breast Cancer
|
||||
15 | Active, not recruiting |
Aprepitant, Palonosetron, and Dexamethasone in Preventing Nausea and Vomiting Caused by Chemotherapy in Patients Receiving Chemotherapy for Metastatic Colorectal Cancer
|
||||
16 | Completed |
APF530 or Palonosetron Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
|
||||
17 | Active, not recruiting |
Multi-Day Doses in Prevention of Nausea and Emesis
|
||||
18 | Completed |
Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.
|
||||
19 | Recruiting |
Granisetron, Dexamethasone, Prochlorperazine, Aprepitant, and Palonosetron in Preventing Nausea in Patients Undergoing Chemotherapy for Breast Cancer
|
||||
20 | Not yet recruiting |
Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
|